Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nanosonics Limited ( (AU:NAN) ) has provided an announcement.
Nanosonics Limited has provided an update on its on-market share buy-back program, confirming it is repurchasing ordinary fully paid shares under an arrangement first notified in December 2025. The company reported that a cumulative 1,704,656 shares had been bought back before the previous trading day, with an additional 400,000 shares repurchased on the prior day alone, underscoring an active capital management strategy that may influence share liquidity and ownership structure.
The latest daily buy-back notification, dated 6 March 2026, reflects ongoing execution of the approved buy-back and follows an earlier update released on 5 March 2026. Continued on-market purchases signal management’s commitment to returning capital or optimizing its balance sheet, a move that can affect earnings per share and may be interpreted by investors as a vote of confidence in the company’s valuation and long-term outlook.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.55 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited is an Australian-listed company trading under the ASX code NAN, with ordinary fully paid shares on issue. The firm operates in the medical technology sector, focusing on infection prevention solutions for healthcare markets, though this specific filing centers on its capital management activities rather than product details.
Average Trading Volume: 517,280
Technical Sentiment Signal: Sell
Current Market Cap: A$982.8M
See more insights into NAN stock on TipRanks’ Stock Analysis page.